carbon tetrachloride has been researched along with y 27632 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arii, S; Imamura, M; Mori, A; Murata, T | 1 |
| Ding, M; Fu, GB; Gao, Y; Huang, WJ; Wang, HY; Wu, HP; Xu, LY; Yan, HX; Zeng, M; Zhang, HD; Zhou, X | 1 |
2 other study(ies) available for carbon tetrachloride and y 27632
| Article | Year |
|---|---|
Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis.
Topics: Actins; Amides; Animals; Carbon Tetrachloride; Enzyme Inhibitors; Infusion Pumps, Implantable; Infusions, Parenteral; Intracellular Signaling Peptides and Proteins; Liver; Liver Cirrhosis, Experimental; Male; Models, Animal; Myocytes, Smooth Muscle; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; Sodium-Calcium Exchanger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction.
Topics: Amides; Animals; Carbon Tetrachloride; CD24 Antigen; Cells, Cultured; Gene Expression; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Pyridines; Pyrimidines; Small Molecule Libraries; Stem Cells | 2021 |